Cancer Family
Malignant Breast Neoplasm
CI-CAN-00000227Explore in graph →
Top-level2,627 active trials43 approved drugs310 evidence items
- NCIt
- C9335
- ICD-10
- C50
- DOID
- 1612
- Other
- 2 more codes
Loading cancer entity…
Loading cancer entity…
Cancer Family
CI-CAN-00000227Explore in graph →
Clinical trials
12,360 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancersTerminated studies (1,368)
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT00003269 | Amifostine Followed by High Dose Chemotherapy in Treating Patients With Hematologic Cancer or Solid Tumors | completed | Phase 2 | 20 | Scripps HealthOTHER | 1 | Jan 10, 2011 | clinicaltrials |
| NCT00161291 | Open Label Trial for Post-Menopausal Women With Newly Diagnosed Operable Breast Cancer | completed | Phase 2 | 28 | University of Alabama at BirminghamOTHER | 1 | Jan 4, 2011 | clinicaltrials |
| NCT01267552 | Study of Axillary Lymphadenectomy Without Drainage for Breast Cancer | completed | Phase 2 / Phase 3 | 240 | Universidade Federal de GoiasOTHER | 1 | Dec 28, 2010 | clinicaltrials |
| NCT00357110 | Anastrozole and Fulvestrant Compared to Anastrozole as Adjuvant Treatment of Postmenopausal Patients With Breast Cancer(@FAME) | completed | Phase 2 | 13 | AstraZenecaINDUSTRY | 3 | Dec 21, 2010 | clinicaltrials |
| NCT00398489 | Docetaxel, Epirubicin, and Cyclophosphamide With or Without Trastuzumab in Treating Women With Locally Advanced Breast Cancer That Can Be Removed By Surgery | unknown | Phase 2 | 94 | Technical University of MunichOTHER | 1 | Nov 9, 2010 | clinicaltrials |
| NCT00994968 | Doxorubicin Hydrochloride, Cyclophosphamide, Docetaxel, and S-1 Before Surgery in Treating Women With Stage II or Stage III Breast Cancer | unknown | Phase 2 | 49 | Yonsei UniversityOTHER | 1 | Oct 29, 2010 | clinicaltrials |
| NCT00480597 | Gemcitabine/Vinorelbine Versus Gemcitabine/Cisplatin Versus Gemcitabine/Capecitabine in Metastatic Breast Cancer | completed | Phase 2 | 141 | Ludwig-Maximilians - University of MunichOTHER | 0 | Oct 28, 2010 | clinicaltrials |
| NCT00002509 | High-Dose Combination Chemotherapy Followed by Peripheral Stem Cell Transplantation in Treating Patients With Poor-Prognosis Breast Cancer | completed | Phase 1 / Phase 2 | — | Temple UniversityOTHER | 1 | Oct 1, 2010 | clinicaltrials |
| NCT01203267 | Weekly Paclitaxel Plus Carboplatin in Preoperative Treatment of Breast Cancer | completed | Phase 2 | 108 | Shanghai Jiao Tong University School of MedicineOTHER | 1 | Sep 16, 2010 | clinicaltrials |
| NCT00524849 | Zometa and Circulating Vascular Endothelial Growth Factor (VEGF) in Breast Cancer Patients With Bone Metastasis | completed | Phase 2 / Phase 3 | 60 | Fudan UniversityOTHER | 1 | Sep 14, 2010 | clinicaltrials |
| NCT01196455 | Capecitabine and Mitomycin C in Treatment of Patients With Metastatic Breast Cancer | unknown | Phase 2 | 39 | Croatian Cooperative Group for Clinical Research in OncologyOTHER | 1 | Sep 8, 2010 | clinicaltrials |
| NCT01195298 | Bevacizumab and Capecitabine in Treatment of Elderly Patients With Metastatic Breast Cancer | unknown | Phase 2 | 88 | South Eastern European Research Oncology GroupOTHER | 1 | Sep 6, 2010 | clinicaltrials |
| NCT01175694 | Dose Optimization for Pulsed-dose-rate (PDR)/High-dose-rate (HDR) Brachytherapy Alone for Early Breast Cancer | unknown | Phase 2 | 200 | University Hospital ErlangenOTHER | 1 | Aug 20, 2010 | clinicaltrials |
| NCT00705315 | Docetaxel/Epirubicin/Bevacizumab as First Line Therapy for Metastatic HER2 Negative Breast Cancer | completed | Phase 1 / Phase 2 | 46 | Hellenic Oncology Research GroupOTHER | 1 | Aug 19, 2010 | clinicaltrials |
| NCT00193115 | Docetaxel Followed by Doxorubicin Plus Cyclophosphamide for Node Positive or High-Risk Primary Breast Cancer | completed | Phase 2 | 32 | SCRI Development Innovations, LLCOTHER | 0 | Aug 4, 2010 | clinicaltrials |
| NCT00191789 | Neoadjuvant Sequential Administration of Two Gemcitabine Combinations in Operable Breast Cancer | completed | Phase 2 | 65 | Eli Lilly and CompanyINDUSTRY | 1 | Jul 27, 2010 | clinicaltrials |
| NCT01170143 | Efficacy and Safety Study of Trastuzumab, Paclitaxel and Carboplatin on HER2+ Preoperative Breast Cancer(PCH) | unknown | Phase 2 | 60 | Fudan UniversityOTHER | 1 | Jul 27, 2010 | clinicaltrials |
| NCT00196846 | Prevention of Chemotherapy Induced Ovarian Failure With Goserelin in BC Patients (ZORO) | completed | Phase 2 | 62 | GBG Forschungs GmbHOTHER | 1 | Jun 14, 2010 | clinicaltrials |
| NCT00006260 | Combination Chemotherapy in Treating Patients With Metastatic Breast Cancer | completed | Phase 2 | 36 | Case Comprehensive Cancer CenterOTHER | 1 | Jun 11, 2010 | clinicaltrials |
| NCT00109993 | Campath-1H + FK506 and Methylprednisolone for GVHD | completed | Phase 2 | 34 | Case Comprehensive Cancer CenterOTHER | 1 | Jun 11, 2010 | clinicaltrials |
| NCT00006261 | Allogeneic Transplantation Using Mini-Conditioning for Treatment of Stage IV Breast Cancer | withdrawn | Phase 2 | 0 | Case Comprehensive Cancer CenterOTHER | 1 | Jun 10, 2010 | clinicaltrials |
| NCT00440089 | Effects of Hands-on-Healing vs. Touch for Fatigued Breast Cancer Survivors | completed | Phase 2 / Phase 3 | 76 | University of California, San DiegoOTHER | 1 | May 25, 2010 | clinicaltrials |
| NCT00410657 | Alemtuzumab and Glucocorticoids in Treating Newly Diagnosed Acute Graft-Versus-Host Disease in Patients Who Have Undergone a Donor Stem Cell Transplant | completed | Phase 2 | 53 | Fred Hutchinson Cancer CenterOTHER | 1 | May 14, 2010 | clinicaltrials |
| NCT00107484 | Magnetic Resonance Imaging Using Ferumoxtran-10 in Finding Metastases to the Axillary Lymph Nodes in Patients With Breast Cancer | completed | Phase 2 | 3 | Virginia Commonwealth UniversityOTHER | 1 | May 3, 2010 | clinicaltrials |
| NCT00892268 | Acupuncture or Medication in Reducing Pain in Postmenopausal Women With Breast Cancer and Joint Pain | terminated | Phase 2 | 68 | University of ArizonaOTHER | 0 | Apr 27, 2010 | clinicaltrials |
| NCT00004013 | Paclitaxel With or Without Trastuzumab Following Peripheral Stem Cell Transplantation in Treating Patients With Refractory Stage IV Breast Cancer | completed | Phase 2 | 60 | Fred Hutchinson Cancer CenterOTHER | 1 | Apr 2, 2010 | clinicaltrials |
| NCT00004157 | Interleukin-11 Plus Filgrastim Prior to Peripheral Stem Cell Transplantation in Patients With Non-Hodgkin's Lymphoma, Hodgkin's Disease, Breast Cancer, or Other Solid Tumors | completed | Phase 2 | — | Fred Hutchinson Cancer CenterOTHER | 1 | Apr 2, 2010 | clinicaltrials |
| NCT00010283 | Beclomethasone in Treating Patients With Graft-Versus-Host Disease of the Esophagus, Stomach, Small Intestine, or Colon | completed | Phase 1 / Phase 2 | — | Fred Hutchinson Cancer CenterOTHER | 1 | Apr 2, 2010 | clinicaltrials |
| NCT00191269 | Gemcitabine Monotherapy for Metastatic Breast Cancer After Anthracycline and Taxane Regimen | completed | Phase 2 | 68 | Eli Lilly and CompanyINDUSTRY | 1 | Mar 17, 2010 | clinicaltrials |
| NCT00334802 | Combination Chemotherapy of Gemcitabine and Paclitaxel for Metastatic Breast Cancer | completed | Phase 2 | 62 | Eli Lilly and CompanyINDUSTRY | 1 | Mar 16, 2010 | clinicaltrials |
| NCT00036621 | A Randomized, Placebo-Controlled Trial of BMS-275291 Given Daily for 12 Months to Women With Stage 1c-IIIA Breast Cancer Receiving Adjuvant Chemotherapy and/or Hormonal Therapy | terminated | Phase 2 | — | Bristol-Myers SquibbINDUSTRY | 1 | Mar 2, 2010 | clinicaltrials |
| NCT00186680 | CD34 Selection of the Peripheral Blood Stem Cell Graft for Autologous Transplant | completed | Phase 1 / Phase 2 | 99 | Stanford UniversityOTHER | 1 | Mar 2, 2010 | clinicaltrials |
| NCT00191854 | Gemcitabine Combinations in Metastatic Breast Cancer (MBC), 1st Line | completed | Phase 2 | 147 | Eli Lilly and CompanyINDUSTRY | 6 | Mar 2, 2010 | clinicaltrials |
| NCT00124111 | A Study of Cyclophosphamide/Methotrexate/5-Fluorouracil (CMF) With Pegfilgrastim in Subjects With Breast Cancer | completed | Phase 2 | — | AmgenINDUSTRY | 0 | Feb 26, 2010 | clinicaltrials |
| NCT00948337 | A Study With Health Educational Material on Health Promotion in Cancer Survivors | unknown | Phase 2 | 326 | National Cancer Center, KoreaOTHER_GOV | 1 | Feb 26, 2010 | clinicaltrials |
| NCT00533364 | Effect of SBG in Patients With Breast Cancer | completed | Phase 1 / Phase 2 | 11 | Biotec Pharmacon ASAINDUSTRY | 1 | Feb 18, 2010 | clinicaltrials |
| NCT00509626 | Physical Activity or Usual Care in Preventing Weight Gain in Women With Stage I or Stage II Breast Cancer Undergoing Chemotherapy | completed | Phase 1 / Phase 2 | 380 | Fox Chase Cancer CenterOTHER | 1 | Feb 12, 2010 | clinicaltrials |
| NCT00914017 | Statins and Breast Cancer Biomarkers | unknown | Phase 2 | 100 | University of VermontOTHER | 1 | Feb 11, 2010 | clinicaltrials |
| NCT00532454 | Evaluation of the Association Between CYP2D6 Genetic Polymorphisms and the Treatment Effect of Tamoxifen | terminated | Phase 2 | 21 | National Cancer Center, KoreaOTHER_GOV | 1 | Feb 10, 2010 | clinicaltrials |
| NCT01023204 | Phase II Study of Weekly Paclitaxel (BMS-181339) in Patient With Breast Cancer | completed | Phase 2 | 68 | Bristol-Myers SquibbINDUSTRY | 0 | Feb 4, 2010 | clinicaltrials |
| NCT00627627 | A Study to Evaluate the Antitumor Activity and Safety of IPI-504 in Patients With Advanced Breast Cancer | withdrawn | Phase 1 / Phase 2 | 56 | MedImmune LLCINDUSTRY | 1 | Feb 3, 2010 | clinicaltrials |
| NCT00154882 | Paclitaxel (Phyxol) and Cisplatin as First-line Chemotherapy for Metastatic Breast Cancer | unknown | Phase 2 | 43 | National Taiwan University HospitalOTHER | 1 | Jan 21, 2010 | clinicaltrials |
| NCT00604435 | Neoadjuvant Endostatin and Chemotherapy for Breast Cancer | completed | Phase 2 | 69 | Xijing HospitalOTHER | 1 | Jan 20, 2010 | clinicaltrials |
| NCT00518583 | Phase II Study in Patients With Operable Breast Cancer | unknown | Phase 2 | 30 | Aptium Oncology Research NetworkNETWORK | 1 | Jan 15, 2010 | clinicaltrials |
| NCT00002937 | Paclitaxel With or Without PSC 833 in Treating Patients With Metastatic Breast Cancer | completed | Phase 2 | 70 | City of Hope Medical CenterOTHER | 2 | Jan 6, 2010 | clinicaltrials |
| NCT00304850 | Polyamine-free Diet to Prevent Post Surgery Hyperalgesia(PoLyDOL) | completed | Phase 2 | 160 | University Hospital, BordeauxOTHER | 1 | Dec 29, 2009 | clinicaltrials |
| NCT00677326 | Histocompatibility Leukocyte Antigen (HLA)-A*0201 Restricted Peptide Vaccine Therapy in Patients With Breast Cancer | terminated | Phase 1 / Phase 2 | 1 | Tokyo UniversityOTHER | 1 | Dec 29, 2009 | clinicaltrials |
| NCT00678509 | Histocompatibility Leukocyte Antigen (HLA)-A*2402 Restricted Peptide Vaccine Therapy in Patients With Breast Cancer | terminated | Phase 1 / Phase 2 | 14 | Tokyo UniversityOTHER | 1 | Dec 29, 2009 | clinicaltrials |
| NCT00303524 | Comparative Study of Oestradiol Suppression: Zoladex 10.8mg/3 Month vs. 3.6mg/Month in ER +ve EBC Pre-menopausal Patients | completed | Phase 2 | 170 | AstraZenecaINDUSTRY | 1 | Dec 23, 2009 | clinicaltrials |
Data updated 23 days agoSource updated Jan 10, 2011source: clinicaltrials